High-frequency p16INK4A promoter methylation is associated with histone methyltransferase SETDB1 expression in sporadic cutaneous melanoma

Experimental Dermatology

Volumn 23, Issue 5, 2014, Pages 332-338

  Kostaki, Maria ^a   Manona, Argyro D ^a   Stavraka, Irene ^a   Korkolopoulou, Penelope ^a   Levidou, Georgia ^a   Trigka, Eleni Andriana ^a   Christofidou, Eleftheria ^a   Champsas, Grigorios ^a   Stratigos, Alexandros J ^a   Katsambas, Andreas ^a   Papadopoulos, Othon ^a   Piperi, Christina ^a   Papavassiliou, Athanasios G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Breslow index; Clark level; Mitotic count; Promoter methylation; SETDB1; Vertical growth

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; HISTONE METHYLTRANSFERASE; KI 67 ANTIGEN; SETDB1 PROTEIN; UNCLASSIFIED DRUG; PROTEIN METHYLTRANSFERASE; SETDB1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CUTANEOUS MELANOMA; CYTOPLASM; FEMALE; GREECE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; SUN EXPOSURE; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; MELANOMA; METABOLISM; MIDDLE AGED; MITOSIS; PROGNOSIS; SKIN TUMOR; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYTOPLASM; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GREECE; HUMANS; KI-67 ANTIGEN; MALE; MELANOMA; MIDDLE AGED; MITOSIS; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROTEIN METHYLTRANSFERASES; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84899536747     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12398     Document Type: Article

References (59)

1. De Vries E, Coebergh J W. Eur J Cancer 2004: 40: 2355-2366.
2. Lasithiotakis K, Krüger-Kragasakis S, Manousaki A et al. Int J Dermatol 2006: 45: 397-401.
3. Sekulic A, Haluska P Jr, Miller A J et al. Mayo Clin Proc 2008: 83: 825-846.
4. Bennett D C. Pigment Cell Melanoma Res 2008: 21: 27-38.
5. Marini A, Mirmohammadsadegh A, Nambiar S et al. J Invest Dermatol 2006: 126: 422-431.
6. Reed J A, Loganzo F Jr, Shea C R et al. Cancer Res 1995: 55: 2713-2718.
7. Bassoli S, Maurichi A, Rodolfo M et al. Exp Dermatol 2013: 22: 411-416.
8. Ghiorzo P, Bonelli L, Pastorino L et al. Exp Dermatol 2012: 21: 718-720.
9. Straume O, Smeds J, Kumar R et al. Am J Pathol 2002: 161: 229-237.
10. Freedberg D E, Rigas S H, Russak J et al. J Natl Cancer Inst 2008: 100: 784-795.
11. Cedar H, Bergman Y. Nat Rev Genet 2009: 10: 295-304.
12. Li H, Rauch T, Chen Z X et al. J Biol Chem 2006: 281: 19489-19500.
13. Nakayama J, Rice J C, Strahl B D et al. Science 2001: 292: 110-113.
14. Fahrner J A, Eguchi S, Herman J G et al. Cancer Res 2002: 62: 7213-7218.
15. Nguyen C T, Weisenberger D J, Velicescu M et al. Cancer Res 2002: 62: 6456-6461.
16. Bachman K E, Park B H, Rhee I et al. Cancer Cell 2003: 3: 89-95.
17. Kondo Y, Shen L L, Issa J P. Mol Cell Biol 2003: 23: 206-215.
18. Molognoni F, Cruz A T, Meliso F M et al. Epigenetics 2011: 6: 450-464.
19. Ceol C J, Houvras Y, Jane-Valbuena J et al. Nature 2011: 471: 513-517.
20. Schultz D C, Ayyanathan K, Negorev D et al. Genes Dev 2002: 16: 919-932.
21. Yang L, Xia L, Wu D Y et al. Oncogene 2002: 21: 148-152.
22. Qian C, Zhou M M. Cell Mol Life Sci 2006: 63: 2755-2763.
23. Litzner B R, Etufugh C N, Stepenaskie S, et al. Am J Dermatopathol 2012: 34: 827-832.
24. Pavey S J, Cummings M C, Whiteman D C et al. Melanoma Res 2002: 12: 539-547.
25. Talve L, Sauroja I, Collan Y et al. Int J Cancer 1997: 74: 255-259.
26. Hoon D S, Spugnardi M, Kuo C et al. Oncogene 2004: 23: 4014-4022.
27. Bodoor K, Haddad Y, Alkhateeb A et al. Asian Pac J Cancer Prev 2014: 15: 75-84.
28. Tellez C S, Shen L, Estécio M R et al. Melanoma Res 2009: 19: 146-155.
29. van der Velden P A, Metzelaar-Blok J A, Bergman W et al. Cancer Res 2001: 61: 5303-5306.
30. Tyler L N, Ai L, Zuo C et al. Mol Pathol 2003: 16: 660-664.
31. Rosas S L, Koch W, da Costa Carvalho M G et al. Cancer Res 2001: 61: 939-942.
32. Straume O, Sviland L, Akslen L A. Clin Cancer Res 2000: 6: 1845-1853.
33. Gonzalgo M L, Bender C M, You E H et al. Cancer Res 1997: 57: 5336-5347.
34. Rastetter M, Schagdarsurengin U, Lahtz C et al. Histol Histopathol 2007: 22: 1005-1015.
35. Jonsson A, Tuominen R, Grafström E et al. J Invest Dermatol 2010: 130: 2809-2817.
36. Kim D H, Nelson H H, Wiencke J K et al. Cancer Res 2001: 61: 3419-3424.
37. Esteller M, Gonzalez S, Risques R A et al. J Clin Oncol 2001: 19: 299-304.
38. Liang J T, Chang K J, Chen J C et al. Oncology 1999: 57: 149-156.
39. Zochbauer-Muller S, Fong K M, Virmani A K et al. Cancer Res 2001: 61: 249-255.
40. Garcia J F, Villuendas R, Algara P et al. Lab Invest 1999: 79: 1453-1459.
41. Gou D, Rubalcava M, Sauer S et al. PLoS ONE 2010: 5: e10581.
42. Cho S, Park J S, Kang Y K. Genes Cells 2013: 18: 694-703.
43. Rodriguez-Paredes M, Martinez de Paz A, Simó-Riudalbas L et al. Oncogene 2013. doi: 10.1038/onc.2013.239. [Epub ahead of print].
44. Watanabe H, Soejima K, Yasuda H et al. Cancer Cell Int 2008: 8: 15.
45. Gargalionis A N, Piperi C, Adamopoulos C et al. Int J Biochem Cell Biol 2012: 44: 1276-1289.
46. Lindgren D, Sjödahl G, Lauss M et al. PLoS ONE 2012: 7: e38863.
47. Cho S, Park J S, Kang Y K. J Biol Chem 2011: 286: 41115-41124.
48. Spyropoulou A, Piperi C, Adamopoulos C et al. Neuromolecular Med 2013: 15: 1-24.
49. Spyropoulou A, Gargalionis A, Dalagiorgou G et al. Neuromolecular Med 2014: 16: 70-82.
50. Macgregor S, Montgomery G W, Liu J Z et al. Nat Genet 2011: 9: 1114-1118.
51. Fritsch L, Robin P, Mathieu J R et al. Mol Cell 2010: 37: 46-56.
52. Yamaguchi H, Wyckoff J, Condeelis J. Curr Opin Cell Biol 2005: 17: 559-564.
53. Gerlitz G, Bustin M. J Cell Sci 2010: 123: 2207-2217.
54. Gerlitz G, Livnat I, Ziv C et al. Traffic 2007: 8: 1521-1529.
55. Tanaka H, Nishioka Y, Yokoyama Y et al. Biochem Biophys Res Commun 2012: 420: 721-726.
56. Kunz M. Eur J Cell Biol 2013: S0171-9335: 00097-6.
57. Dong C, Wu Y, Wang Y et al. Oncogene 2013: 32: 1351-1362.
58. Yokoyama Y, Hieda M, Nishioka Y et al. Cancer Sci 2013: 104: 889-895.
59. Park Y S, Jin M Y, Kim Y J et al. Ann Surg Oncol 2008: 15: 1968-1976.